Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOPT anidulafungin pharmacokinetic study in morbid obesity
NL-OMON40398Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2014
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anidulafungin in candidiasis and mycoses, sponsored by Radboud University Medical Center. Primary endpoints: AUC0-inf of anidulafungin, Cmax of anidulafungin and 2 more. Started Aug 2014; status: active, not recruiting.
02
Drugs
anidulafungin
03
Conditions
candidiasismycoses
Beyond the preview
Go deeper on NL-OMON40398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40398.